NCT06735001Recruiting
Identification of the Metabolic Signature of Atrial Fibrillation for Personalized Prevention
Source: ClinicalTrials.gov · Last updated 9 Jun 2026
Brief summary (registry, in English)
Atrial fibrillation (AF) is a major public health problem. The efficacy of the existing techniques is limited in the more aggressive forms. It is therefore necessary to develop approaches, in particular the identification of relevant biomarkers, to prevent the onset, recurrence or progression of AF in at-risk patients. The objective of this study is to describe the longitudinal metabolic and biomolecular signature of AF in patients eligible for cardiac ablation.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 400 (estimated)
- First submitted
- 21 Nov 2024
- Start date
- 10 Mar 2025
- Primary completion date
- Oct 2029
- Lead sponsor
- University Hospital, Bordeaux
- Diseases
- Atrial fibrillation
- NCT number
- NCT06735001
What you commit to
- Study type: Interventional
- Planned participants: 400
- From 10 Mar 2025 to the primary completion date, Oct 2029
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Active tumor pathology (benign or malignant)
- Chronic inflammation or autoimmune disease
- Chronic liver disease
- Myocardial infarction within the last 8 weeks
Age
- Age \< 18 years
Other
- Lack of informed consent
- Gestating women (pregnancy test carried out as part of care for FA patients, contraception, or menopause for women in control groups)
- Persons under administrative or judicial protection
- Endocarditis or pericarditis in progress or within the 3 last months
Who the study is looking for
- Age ≥ 18 years, all genders, and ethnic origins
- Free, informed, and written consent signed
- Person affiliated to or benefiting from a social security scheme
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Hospital of Bordeaux Coordinator of this site? Confirm its status | Pessac | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.